Alkem Laboratories Receives EU GMP Certificate for Daman Facility
Alkem Laboratories Limited announced on March 21, 2026, that it has received a 'Certificate of GMP Compliance of a Manufacturer' from the Malta Medicines Authority for its manufacturing facility located in Daman, India. This follows a GMP inspection by the Malta Medicines Authority that occurred on December 9, 2025.The certificate is valid for three years from the date of inspection. The facility’s GMP compliance is crucial for continued operations and exports within the European Union. A copy of the certificate will be available on the company’s website.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.